ACTIMMUNE (interferon gamma-1b,recomb.)
INTERFERON GAMMA · CHRONIC GRANULOMATOUS DISEASE ·+1
HORIZON/AMGEN
Drug class
Interferon Gamma
Interferon gamma represents a distinct biologic drug class of type II interferons, clinically represented by the recombinant cytokine interferon gamma-1b. Read more about Interferon Gamma
1 drugs in this class 1 manufacturers
Drugs in Interferon Gamma
Filter & compare in the drug finder →
Opens the drug finder with Interferon Gamma preselected. Add indication or manufacturer filters there.
Interferon gamma represents a distinct biologic drug class of type II interferons, clinically represented by the recombinant cytokine interferon gamma-1b.
Agents in this class exert immunomodulatory, antiviral, and macrophage-activating effects by binding to specific cell-surface interferon-gamma receptors, stimulating intracellular JAK-STAT signaling to enhance phagocytic oxidative metabolism and antibody-dependent cellular cytotoxicity.
Therapeutically, it is indicated to reduce the frequency and severity of recurrent, life-threatening infections in patients with chronic granulomatous disease and to delay disease progression in severe, malignant osteopetrosis.
-
clinimmsoc.org
Interferon gamma represents a distinct biologic drug class of type II interferons, clinically represented by the recombinant cytokine interferon gamma-1b Agents in this class exert immunomodulatory, antiviral, and macrophage-activating effects by binding to specific cell-surface interferon-gamma receptors, stimulating intracellular JAK-STAT signaling to enhance phagocytic oxidative metabolism and antibody-dependent cellular cytotoxicity Therapeutically, it is indicated to reduce the frequency an...
-
cancer.gov
Interferon gamma represents a distinct biologic drug class of type II interferons, clinically represented by the recombinant cytokine interferon gamma-1b Agents in this class exert immunomodulatory, antiviral, and macrophage-activating effects by binding to specific cell-surface interferon-gamma receptors, stimulating intracellular JAK-STAT signaling to enhance phagocytic oxidative metabolism and antibody-dependent cellular cytotoxicity
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.